Black Diamond Therapeutics Inc - Trending symbols
Notifications
Type | Notification | Date |
---|---|---|
RSI Oversold | Oversold RSI (Relative Strength Index) | 2024-11-21 |
Trends
2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Accumulated Other Comprehensive Income | -364 | 337 | -27 | -68 | -95 | -20 | -115 | 222 | 107 | |
Long-term Assets Other | 1,168 | 60 | 1,228 | -409 | 819 | 4 | 823 | -823 | 0 | |
Total Stockholder Equity | 196 | 172,364 | 172,560 | -20,189 | 152,371 | -19,140 | 133,231 | -468,220 | -334,989 | |
Liabilities and Stockholders Equity | 248 | 219,234 | 219,482 | -20,648 | 198,834 | -18,418 | 180,416 | -474,845 | -294,429 | |
Reconciled Depreciation | 123 | 2 | 125 | 3 | 128 | 1 | 129 | -510 | -381 | |
Depreciation and Amortization | 123 | 2 | 125 | 3 | 128 | 1 | 129 | -2,361 | -2,232 | |
EBIT | -26,080 | 979 | -25,101 | 2,557 | -22,544 | 1,452 | -21,092 | 91,092 | 70,000 | |
Operating Income | -26,080 | 401 | -25,679 | 2,506 | -23,173 | 1,049 | -22,124 | 93,007 | 70,883 | |
Total Other Income Expense Net | 125,683 | -125,511 | 172 | 71 | 243 | 227 | 470 | -1,353 | -883 | |
Research Development | 17,756 | 5,064 | 22,820 | 3,899 | 26,719 | 907 | 27,626 | -104,694 | -77,068 | |
Income before Tax | -22,626 | -7,675 | -30,301 | -4,050 | -34,351 | -726 | -35,077 | 134,680 | 99,603 | |
Net Income | -22,626 | -7,675 | -30,301 | -4,050 | -34,351 | -726 | -35,077 | 134,680 | 99,603 | |
Selling General Administrative | 5,427 | 2,466 | 7,893 | 103 | 7,996 | -258 | 7,738 | -31,335 | -23,597 | |
EBITDA | -22,611 | -8,083 | -30,694 | -3,637 | -34,331 | -703 | -35,034 | 135,699 | 100,665 | |
Total Operating Expenses | 23,183 | 7,530 | 30,713 | 4,002 | 34,715 | 649 | 35,364 | -136,029 | -100,665 |
Comments
How you think about this?